Dyne therapeutics market cap

Author: fgrw

August undefined, 2024

WebApr 5, 2024 · Dyne Therapeutics, Inc. Common Stock (DYN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. WebOur data points out that Dyne Therapeutics, Inc. (DYN) is ranked #5407 out of 13000 companies on February - 2024. DYN's Market Capitalization is $700 million and the …

Dyne Therapeutics: DYN Stock Price Quote & News Robinhood

WebDyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle ... WebApr 11, 2024 · Dyne Therapeutics Stock Performance. NASDAQ DYN opened at $8.82 on Tuesday. The stock has a market cap of $496.90 million, a price-to-earnings ratio of -2.72 and a beta of 0.24. philzas streaming playlist

DYN : Dyne Therapeutics Inc - MSN Money

WebMar 13, 2024 · About Market Cap. As of the previous market close, Dyne Therapeutics, Inc. has a market cap of $737.47M, which represents its share price of $13.09 multiplied … WebInformation on stock, financials, earnings, subsidiaries, investors, and executives for Dyne Therapeutics. Use the PitchBook Platform to explore the full profile. Information on stock, financials, earnings, subsidiaries, investors, and executives for Dyne Therapeutics. ... Market Cap Shares Average Volume EPS; $9.38: $9.11: $4.30 - $15.63 ... WebDyne Therapeutics, Inc. Analyst Report: Xcel Energy Inc. Xcel Energy manages utilities serving 3.7 million electric customers and 2.1 million natural gas customers in eight states. Discover historical prices for DYN stock on Yahoo Finance. View daily, weekly or … Get the detailed quarterly/annual income statement for Dyne Therapeutics, Inc. … View the basic DYN option chain and compare options of Dyne Therapeutics, … Find out the direct holders, institutional holders and mutual fund holders for … Dyne Therapeutics, Inc. 1560 Trapelo Road Waltham, MA 02451 United States 781 … See Dyne Therapeutics, Inc. (DYN) stock analyst estimates, including earnings … Find out all the key statistics for Dyne Therapeutics, Inc. (DYN), including … Dyne Therapeutics to Present at Upcoming Investor Conferences. WALTHAM, … See Dyne Therapeutics, Inc. (DYN) Environment, Social and Governance … Find the latest Dyne Therapeutics, Inc. (DYN) stock quote, history, news and … tsio 520 wb

Dyne Therapeutics, Inc. (NASDAQ:DYN) Given Average …

WebDyne Therapeutics Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... Market Cap: capitalization or market value of a stock is simply the market value of all outstanding shares. It is computed by multiplying the market price by the number of outstanding shares. WebMar 17, 2024 · Dyne Therapeutics stock opened at $12.85 on Friday. Dyne Therapeutics has a 52 week low of $4.30 and a 52 week high of $15.63. The firm has a market cap of … philza statue for technoWebFeb 28, 2024 · Latest Dyne Therapeutics Inc Stock News. As of February 28, 2024, Dyne Therapeutics Inc had a $681.8 million market capitalization, putting it in the 59th percentile of companies in the Biotechnology & Medical Research industry. Dyne Therapeutics Inc does not have a meaningful P/E due to negative earnings over the last … philzas minecraft skin

"WebApr 6, 2024 · With Dyne Therapeutics stock trading at $15.00 per share, the total value of Dyne Therapeutics stock (market capitalization) is $845.07M. Dyne Therapeutics … " - Dyne therapeutics market cap

Dyne therapeutics market cap

Dyne Therapeutics, Inc. (NASDAQ:DYN) Receives Consensus …

WebJan 27, 2024 · With a market capitalization of US$963m, Dyne Therapeutics is a decent size, so it is probably on the radar of institutional investors. In the chart below, we can see that institutions own shares ... WebFounded. 2024. Dyne Therapeutics, Inc. engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystroph.

Did you know?

WebDyne Therapeutics (DYN) has a Smart Score of 7 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. ... Market Cap. $495.76M. Enterprise Value $263.49M. Total Cash (Recent Filing) $256.01M. Total Debt (Recent Filing) $30.48M. Price to Earnings (P/E)-2.7. Beta 0.93. Next … WebDyne Therapeutics to Present at Upcoming Investor Conferences. WALTHAM, Mass., March 07, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that …

WebMar 20, 2024 · Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with … WebDyne Therapeutics Inc Working Capital Per Revenue on the trailing twelve month basis from the forth quarter 2024 to forth quarter 2024, Trends and Ranking, Fundamental Ratios - CSIMarket Company Name, Ticker, Suppliers, else..

Web19 hours ago · Find the latest Price To Free Cash Flow for Dyne Therapeutics (DYN) ... Large-Cap Trader; ... 03/23/23-11:00AM EST Market News Video Dyne Therapeutics Receives FDA Orphan Drug and Rare Pediatric ... WebJan 18, 2024 · Dyne Therapeutics had its IPO a year ago. The clinical-stage biotech has $407.5 million in cash but no revenue. The company specializes in treating serious …

WebApr 10, 2024 · Dyne Therapeutics Inc. company and executive profile by Barron's. View the latest DYN company infomation and executive bios.

WebApr 6, 2024 · 91,5%. More Financials. Company. Dyne Therapeutics Inc. is a muscle disease company. The Company is focused on advancing therapeutics for patients with genetically driven diseases. It is utilizing its FORCE platform to overcome the limitations of muscle tissue delivery and oligonucleotide therapeutics for muscle diseases. philza starting stream musicWebMar 29, 2024 · Get a real-time Dyne Therapeutics, Inc. (DYN) stock price quote with breaking news, financials, statistics, charts and more. ... Market Cap: 628.17M: Revenue (ttm) n/a: Net Income (ttm)-168.10M: Shares Out 56.34M: EPS (ttm)-3.23: PE Ratio ... Chardan Initiates Coverage On These 'Intriguing Small-Cap Stories" Chardan Research … philza starting musicWebDyne Therapeutics Inc market cap is $489.02M. What is the 52-week high for Dyne Therapeutics Inc? 52 week high is the highest price of a stock in the past 52 weeks, or … tsio 550 rails and shrouds used partsWebView the latest Dyne Therapeutics Inc. (DYN) stock price, news, historical charts, analyst ratings and financial information from WSJ. tsiodfo meaningWebReal time Dyne Therapeutics (DYN) stock price quote, stock graph, news & analysis. philzas sonWebApr 11, 2024 · Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven … tsio 520 be overhaulWebDYN stock forecast Our latest prediction for Dyne Therapeutics Inc's stock price was made on the Dec. 15, 2024 when the stock price was at 13.59$.. In the short term (2weeks), DYN's stock price should underperform the market by -4.52%.During that period the price should oscillate between -12.37% and +6.64%.. In the medium term (3months), DYN's stock … tsio aircraft engine meaning